← All trials
NCT04482699
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 30, 2020
- Primary completion
- Dec 30, 2021
- Completion date
- Jun 1, 2022
- First posted
- Jul 22, 2020
- Last posted
- Dec 19, 2020
- Enrollment
- 88
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Rapa Therapeutics LLCLead sponsor
- Hackensack University Medical CenterCollaborator
- Rapa Therapeutics LLCStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.